About this event

  • Date and time Wed 8 May 2024 from 9:00am to 5:45pm
  • Location Online
  • Organised by Geriatrics and Gerontology

Register now for this exciting and crucial event aimed at delving into the complexities of dementia across various fronts, from molecular science to clinical application.

Experts will discuss state-of-the-art care developments in dementia and provide insights at a molecular level, deepening your understanding of its pathophysiology. Learn about the new treatment options that have the potential to revolutionise patient care outcomes, the different subtypes of dementia with their unique therapeutic interventions and clinical approaches, and the holistic approach to assist in its multi-faceted layers of care. Also, learn the role of cognitive clinics, early diagnosis and living with dementia and its prognosis.

By attending this webinar, you will understand:

  • New molecular targets in dementia and how this can change the prognosis and outcomes
  • New therapeutic interventions in dementia, the current drug trials and their efficacy to help improve outcomes
  • Early diagnosis and prevention of dementia, the role of new blood tests, new scanning and new diagnostic methods to detect dementia early before there is a cumulative neuronal loss in the brain

This webinar is available for on-demand viewing. The webinar recording will be available for registered event participants up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.

Follow us on:

Facebook
Instagram
LinkedIn
Twitter
YouTube

We would like to thank our sponsor Life Molecular Imaging (LMI) for their support of this meeting.
Please note that the scientific programme and content has not been influenced in any way by the sponsors.

Tickets

Standard pricing available until 07 May 2024.

Member

RSM Fellow RSM Trainee RSM Associate RSM Retired Fellow RSM Student
£36.00 £27.00 £27.00 £27.00 £18.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Non Healthcare Professional Student
£66.00 £50.00 £50.00 £50.00 £33.00

Key speakers

Craig Ritchie

Professor Craig Ritchie

Founder and CEO of Scottish Brain Sciences

Speaker's biography

Prof Craig Ritchie is Founder and CEO of Scottish Brain Sciences and Professor of Brain Health and Neurodegenerative Medicine at the University of St Andrew’s, having moved from his role as Senior Lecturer in the Centre for Mental Health at Imperial College London in October 2014. He completed his PhD at UCL through an MRC Health Services Research Fellowship and was appointed as Senior Lecturer in Old Age Psychiatry at Imperial College London in 2007. He has also served as R&D Director at West London Mental Health Trust from 2010-14 and Deputy Director of the London Northwest NIHR Clinical Research Network. In 2014 he was appointed as Chair in Psychiatry of Ageing at the University of Edinburgh. In 2015 he established the Centre for Dementia Prevention and that year took on the academic leadership role of the EPAD (European Prevention of Alzheimer’s Dementia) Programme. Between 2017 and 2022 he was the elected Chair of the Scottish Dementia Research Consortium and in 2020 he founded and was the inaugural Director of Brain Health Scotland. He has published over 400 academic papers, conference abstracts and book chapters and secured approximately €100M of grant funding in his career to date. His main research interest is the interface between clinical trials and translational epidemiology (cohort studies) with a drive to develop the infrastructures at a national level (in Scotland) to prepare health systems and prosecute rapid ‘research into practice’ programmes. He is a pioneer and leading advocate for the Brain Health Movement that works across the life course from primary to secondary prevention of late-stage neurodegenerative disease. This involved working at a public health and policy level as well as developing and implementing Brain Health Clinics across Scotland following ‘The Scottish Model for Brain Health Services’. This work has led Scotland to being one of the Flagship Countries in the Davos Alzheimer’s Collaborative for Health Care Readiness. He established Scottish Brain Sciences in summer 2022 to accelerate the development of both diagnostics and therapeutics for early-stage neurodegenerative disease and moved full time into the role of CEO of this company in January 2023.

 

Ruth Mizoguchi

Dr Ruth Akiyo Mizoguchi

Care of the Elderly Consultant, Chelsea and Westminster NHS Foundation Trust

Speaker's biography

Dr Ruth Akiyo Mizoguchi is a Care of the Elderly Consultant and Dementia Lead at Chelsea and Westminster NHS Foundation Trust (London, UK) after working at the Royal Free NHS Foundation Trust from 2012- 2018.  She is an Honorary Senior Clinical lecturer at Imperial College where she provides dementia teaching to medical students and doctors.  She originally obtained a medical degree at Tokai University School of Medicine, Japan and then completed further medical training at Imperial College, London. She received her specialist training in general internal medicine and geriatric medicine in London. During her specialist training she worked in Hong Kong for a year where she developed interest in dementia. She also gained research experience in Neuroimaging & Dementia at Imperial College. She visited UCSF Memory Aging Center, USA . She set up the Multidisciplinary team Memory Clinic with Neurologists at Chelsea and Westminster Hospital.

Agenda

View the programme

Welcome and introduction

Dr Mashkur Khan, President of the Geriatrics and Gerontology Section

New therapies in Alzheimer’s disease

Dr Robert Barber, Consultant Old Age Psychiatrist, Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust

Prevention and treatments

Professor Craig Ritchie, CEO and Founder, Scottish Brain Sciences, and Professor of Brain Health and Neurodegenerative Medicine, University of St Andrew’s

Comfort break
Continence in dementia

Dr Andy Northcott, Senior Lecturer in Sociology of Medicine, Geller institute of Ageing and Memory

The many faces of dementia: The clinical subtypes vascular, frontotemporal degeneration and Lewy body dementia

Dr Philip Weston, Wellcome Trust Clinician Scientist and Honorary Consultant Neurologist, Dementia Research Centre and UCL Queen Square Institute of Neurology

Lunch break
Update in Alzheimer's Disease: Diagnosis and treatment

Dr Ruth Akiyo Mizoguchi, Care of the Elderly Consultant & Dementia Lead, Chelsea & Westminster NHS Foundation Trust

Personal perspectives: people living with dementia

Dr Laura Cole, Geriatrics Section President-elect and Senior Lecturer, University of West London

Practical tips on dementia care

Dr Raad Nari, Consultant in Elderly Care, Epsom and St Helier University Hospitals NHS Trust

Round table discussion
Closing remarks

Dr Mashkur Khan

Close of meeting

Sponsors

Location

Online

Disclaimer: 

Registration for this event will close 1 hour prior to start time. Late registrations will not be accepted.

The agenda is subject to change at any time.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member